Sign in to view content

Quality Assessment of a New Silicone-Free Syringe Developed for Intravitreal Injections

Gustavo Barreto de Melo, MD, PhD, FASRS

Video
Published 2021

Related

Results from Part 1 of the Phase 2/3 SIGLEC Trial Assessing AVD-104 for Geographic Atrophy: Glyco-immunologic Modulation of Macrophage Activity
Rishi P. Singh, MD
Updates from the Field
2024
Reoperation for Proliferative Vitreoretinopathy
Gary W. Abrams, MD
Updates from the Field
2017
Differences in Intravitreal Silicone Oil Following Multiple Bevacizumab, Ranibizumab, and Aflibercept Injections
John T. Thompson, MD
Updates from the Field
2019

Category: Instrumentation and Devices

See more